Related Experiment Videos
Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120
M Moulard1, H Lortat-Jacob, I Mondor
1Centre d'Immunologie de Marseille-Luminy, 13288 Marseille Cedex 9, France.
Journal of Virology
|January 22, 2000
Summary
The HIV-1 gp120 V3 loop binds polyanions, but a second site in the coreceptor binding region also interacts with them. This interaction selectively targets specific HIV-1 variants, offering a potential therapeutic target.
Area of Science:
- Virology
- Immunology
- Structural Biology
Background:
- The gp120 V3 loop of human immunodeficiency virus type 1 (HIV-1) is known to bind polyanions, influencing virus infectivity and neutralization.
- Previous studies focused on T-cell-line-adapted, CXCR4-using HIV-1, limiting understanding of other gp120 regions' polyanion binding capabilities.
Purpose of the Study:
- To investigate potential secondary polyanion binding sites on HIV-1 gp120 beyond the V3 loop.
- To characterize the role of the coreceptor binding region in gp120-polyanion interactions.
- To explore the differential binding of polyanions to various HIV-1 gp120 tropisms (X4, R5, R5X4).
Main Methods:
- Monoclonal antibody inhibition assays.
- Labeled heparin binding experiments.
- Surface plasmon resonance (SPR) studies.
- Analysis of mutated gp120 variants.
- Molecular modeling of gp120 electrostatic potential.
Main Results:
- A second polyanion binding site was identified on gp120, likely within the conserved coreceptor binding region.
- Polyanion binding to the coreceptor site interfered with gp120-CXCR4 interaction but not gp120-CD4 interaction.
- Polyanion binding was significant for X4 and R5X4 gp120 but weak or undetectable for R5 gp120.
- The V3 loop was the primary determinant for polyanion binding, with subtle influences from other regions like V1/V2 loops and termini.
Conclusions:
- HIV-1 gp120 exhibits selective polyanion binding, involving both the V3 loop and the coreceptor binding region.
- The conserved coreceptor binding surface represents a potential novel and conserved target for therapeutic interventions against HIV-1.